Literature DB >> 30033344

Ureaplasma spp. lipid-associated membrane proteins induce human monocyte U937 cell cycle arrest through p53-independent p21 pathway.

Xucheng Huang1, Yingli Qiao1, Yixuan Zhou1, Zhi Ruan1, Yingying Kong1, Guoli Li1, Xinyou Xie2, Jun Zhang3.   

Abstract

Ureaplasma spp. are known to be associated with human genitourinary tract diseases and perinatal diseases and Ureaplasma spp. Lipid-associated membrane proteins (LAMPs) play important roles in their related diseases. However, the exact mechanism underlying pathogenesis of Ureaplasma spp. LAMPs is largely unknown. In this study, we explored the pathogenic mechanisms of Ureaplasma spp. LAMPs by elucidating their role in modulating the cell cycle and related signaling pathways in human monocytic cell U937, which is highly related to the inflammatory and protective effect in infectious diseases. We utilized the two ATCC reference strains (Ureaplasma parvum serovar 3 str. ATCC 27,815 (UPA3) and Ureaplasma urealyticum serovar 8 str. ATCC 27,618 (UUR8)) and nine clinical isolates which including both UPA and UUR to study the effects of Ureaplasma spp. LAMPs on U937 in vitro. We found that LAMPs derived from UUR8 and both UPA and UUR of clinical strains markedly inhibited the cell proliferation, while UPA3 LAMPs suppressed slightly. Besides, the result of flow cytometry analysis indicated all the Ureaplasma spp. LAMPs could arrest U937 cells in G1 phase. Next, we found that the cell cycle arrest was associated with increased levels of p53 and p21, and a concomitant decrease in the levels of CDK2, CDK4, CDK6 and cyclin E1 at both transcriptional and translational levels after treatment with LAMPs derived from UUR8 or clinical strains, while only cyclin E1 was down-regulated after treatment with UPA3 LAMPs. Further study showed that p53 down-regulation had almost no effect on the distribution of cell cycle and the expression of p21. In conclusion, this study demonstrated that LAMPs derived from UUR8 and clinical strains could inhibit the proliferation of U937 cells by inducing G1 cell cycle arrest through increasing the p21 expression in a p53-independent manner, while UPA3 LAMPs could induce the cell cycle arrest slightly. Our study could contribute to the understanding of Ureaplasma spp. pathogenesis, which has potential value for the treatment of Ureaplasma spp. infections.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cell cycle arrest; Lipid-associated membrane proteins (LAMPs); U937; Ureaplasma spp.; p53-independent

Mesh:

Substances:

Year:  2018        PMID: 30033344     DOI: 10.1016/j.ijmm.2018.07.005

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  4 in total

1.  Heterologous Expression, Purification, and Immunomodulatory Effects of Recombinant Lipoprotein GUDIV-103 Isolated from Ureaplasma diversum.

Authors:  Manoel Neres Santos-Junior; Wanderson Souza Neves; Ronaldo Silva Santos; Palloma Porto Almeida; Janaina Marinho Fernandes; Bruna Carolina de Brito Guimarães; Maysa Santos Barbosa; Lucas Santana Coelho da Silva; Camila Pacheco Gomes; Beatriz Almeida Sampaio; Izadora de Souza Rezende; Thiago Macedo Lopes Correia; Nayara Silva de Macedo Neres; Guilherme Barreto Campos; Bruno Lopes Bastos; Jorge Timenetsky; Lucas Miranda Marques
Journal:  Microorganisms       Date:  2022-05-16

2.  Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Wenyan Lv; Jingyu Wang; Shubao Zhang
Journal:  Oncol Lett       Date:  2019-09-12       Impact factor: 2.967

Review 3.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

4.  Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.

Authors:  Feng Zeng; Liangliang Huang; Xiaoming Cheng; Xiaoli Yang; Taolang Li; Guoli Feng; Yingqi Tang; Yan Yang
Journal:  Cancer Cell Int       Date:  2018-10-01       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.